Skip to content

FinSMEs

REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS

Search for:

Facebook
Twitter
Linkedin

Navigation

Site navigation

USA
UK
Germany
Canada
China
Russia
India
France
Italy

Home
Amal Therapeutics

Amal Therapeutics

Boehringer Ingelheim

Germany Switzerland

Boehringer Ingelheim Acquires Amal Therapeutics, For Up To €325M

Published on July 15, 2019By FinSMEs

cancer

Amal Therapeutics Closes €29M in Series B Funding

Published on November 12, 2018By FinSMEs

cancer

Amal Therapeutics Raises €8M in First Closing of Series B Funding Round

Published on September 6, 2017By FinSMEs

Amal Therapeutics Raises CHF3M in Series A Funding

Published on March 30, 2016By FinSMEs

funding Germany Start Up Switzerland venture capital

Amal Therapeutics Raises Seed Funding

Published on February 21, 2014February 21, 2014By FinSMEs

The Daily Deal Newsletter – Sign Up

Email address:

Leave this field empty if you're human:

About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter
FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

Privacy Policy FinSMEs is owned by FinSMEs Ltd - 86 - 90 Paul Street - London, UK - EC2A 4NE - e-mail: info@finsmes.com

Follow FinSMEs on:

Sign-up now to the Daily Newsletter